Suppr超能文献

年龄-D-二聚体-白蛋白评分在接受经皮冠状动脉介入治疗的急性心肌梗死患者中的预后价值。

The Prognostic Value of the Age-D-Dimer-Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

机构信息

Department of Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.

出版信息

Thromb Haemost. 2024 Feb;124(2):166-176. doi: 10.1055/s-0043-1773764. Epub 2023 Aug 29.

Abstract

BACKGROUND

The Age-D-dimer-Albumin (ADA), the CREDO-Kyoto, and the PARIS scores have been established to predict thrombotic events. However, the prognostic performance of these scores compared to the GRACE score in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) has not been reported.

METHODS

Consecutive AMI patients treated with PCI were retrospectively enrolled at a teaching hospital in China from January 2016 to December 2019. The primary endpoint was all-cause mortality and the secondary endpoint was cardiac death. Harrell's C-index and net reclassification improvement (NRI) were used to compare the prognostic value of these scores with the GRACE score for mortality.

RESULTS

Of the 1,578 patients enrolled, the mean age was 62.5 years, and 23.5% were female. During a median follow-up of 3.8 years, 146 all-cause deaths and 80 cardiac deaths occurred. The ADA score showed a better prognostic performance than the GRACE (Harrell's C-index: 0.800 vs. 0.749;  = 0.003), the CREDO-Kyoto (Harrell's C-index: 0.800 vs. 0.765; NRI = 0.348,  < 0.001), and the PARIS scores (Harrell's C-index: 0.800 vs. 0.694; NRI = 0.556,  < 0.001). In the multivariable Cox regression analysis, the ADA score was independently associated with all-cause mortality (hazard ratio [HR] = 1.641 per 10-point increment, 95% confidence interval [CI]: 1.397-1.929) and cardiac death (HR = 1.636 per 10-point increment, 95% CI: 1.325-2.020). The risk of all-cause mortality and cardiac death increased with the rising of the ADA score.

CONCLUSION

The ADA score showed a better prognostic performance than the GRACE, the CREDO-Kyoto, and the PARIS scores in patients with AMI undergoing PCI, which was a potential predictive tool for mortality.

摘要

背景

年龄-二聚体-白蛋白(ADA)、CREDO-Kyoto 和 PARIS 评分已被用于预测血栓事件。然而,这些评分在接受经皮冠状动脉介入治疗(PCI)的急性心肌梗死(AMI)患者中的预后表现与 GRACE 评分相比尚未得到报道。

方法

本研究回顾性纳入了 2016 年 1 月至 2019 年 12 月在中国一家教学医院接受 PCI 治疗的连续 AMI 患者。主要终点为全因死亡率,次要终点为心源性死亡。Harrell's C 指数和净重新分类改善(NRI)用于比较这些评分与 GRACE 评分对死亡率的预后价值。

结果

在纳入的 1578 例患者中,平均年龄为 62.5 岁,23.5%为女性。中位随访 3.8 年后,发生 146 例全因死亡和 80 例心源性死亡。ADA 评分的预后表现优于 GRACE(Harrell's C 指数:0.800 比 0.749;P=0.003)、CREDO-Kyoto(Harrell's C 指数:0.800 比 0.765;NRI=0.348,P<0.001)和 PARIS 评分(Harrell's C 指数:0.800 比 0.694;NRI=0.556,P<0.001)。多变量 Cox 回归分析显示,ADA 评分与全因死亡率(每增加 10 分,危险比[HR]为 1.641,95%置信区间[CI]:1.397-1.929)和心源性死亡率(HR 为 1.636/每增加 10 分,95%CI:1.325-2.020)独立相关。随着 ADA 评分的升高,全因死亡率和心源性死亡率的风险增加。

结论

ADA 评分在接受 PCI 的 AMI 患者中的预后表现优于 GRACE、CREDO-Kyoto 和 PARIS 评分,是一种潜在的死亡率预测工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验